
Eutelmi AMH 40mg/5mg/12.5mg Tablet
Marketer
Europa Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Eutelmi AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Valsartan 40mg/5mg/12.5mg tablets are a triple-combination therapy for managing hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, significantly reducing the risk of future cardiovascular events such as stroke and myocardial infarction. This medication may be taken with or without food, with dosage adjusted based on individual response and health status. Consistent daily administration at the same time is recommended. Continued use, as directed by your physician, is crucial. Due to its diuretic component, increased urination is expected; therefore, avoid late-evening doses. Regular use, even during asymptomatic periods, maximizes therapeutic efficacy. Discontinuation may heighten the risk of stroke or heart attack. Commonly reported side effects include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Maintain adequate hydration to mitigate potential side effects such as dry mouth, thirst, and muscle weakness. Prior to initiating treatment, disclose any pre-existing liver or kidney disease. Pregnant or lactating individuals must seek medical counsel before use. Inform your doctor of all concurrent medications, particularly those for hypertension or cardiovascular conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to ensure optimal treatment effectiveness.
Uses of Eutelmi AMH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Eutelmi AMH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Eutelmi AMH 40mg/5mg/12.5mg Tablets. Ingest the tablets whole; do not crush, chew, or divide them. These tablets can be administered with or without food, however, consistent daily timing is recommended.
Common Side effects of Eutelmi AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Eutelmi AMH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the 40mg/5mg/12.5mg Eutelmi AMH tablet whole; avoid chewing, crushing, or fracturing it. This medication can be taken with or without food, though consistent daily timing is recommended.
How Eutelmi AMH 40mg/5mg/12.5mg Tablet works:
Each Eutelmi AMH 40mg/5mg/12.5mg tablet unites telmisartan (an angiotensin receptor blocker or ARB), amlodipine (a calcium channel blocker or CCB), and hydrochlorothiazide (a diuretic). Telmisartan and amlodipine reduce blood pressure by promoting vasodilation, widening and relaxing blood vessels. Hydrochlorothiazide lowers blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to vasodilation over time, enhancing circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Eutelmi AMH 40mg/5mg/12.5mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Eutelmi AMH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation is contraindicated with Eutelmi AMH 40mg/5mg/12.5mg tablets due to the potential for infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by side effects of Eutelmi AMH 40mg/5mg/12.5mg Tablets. These potential side effects include dizziness, headaches, nausea, and fatigue, all of which can compromise concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Eutelmi AMH 40mg/5mg/12.5mg Tablets. A physician should be consulted regarding potential dosage modifications. Eutelmi AMH 40mg/5mg/12.5mg Tablets are generally not advised for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Eutelmi AMH 40mg/5mg/12.5mg tablets. Dosage modification of Eutelmi AMH 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Eutelmi AMH 40mg/5mg/12.5mg Tablet :
Should you forget to take your Eutelmi AMH 40mg/5mg/12.5mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Eutelmi AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
